You are here


Found 778 results
Author Title [ Type(Desc)] Year
Journal Article
Ehrt S, Schnappinger D.  2003.  Isolation of plasmids from E. coli by alkaline lysis.. Methods Mol Biol. 235:75-8.
Ehrt S, Schnappinger D.  2003.  Isolation of plasmids from E. coli by boiling lysis.. Methods Mol Biol. 235:79-82.
Tsukuda T, Bauchwitz R, Holloman WK.  1989.  Isolation of the REC1 gene controlling recombination in Ustilago maydis.. Gene. 85(2):335-41.
Bauchwitz R, Holloman WK.  1990.  Isolation of the REC2 gene controlling recombination in Ustilago maydis.. Gene. 96(2):285-8.
Nathan C, Nussenzweig MC, Pulvirenti T.  2017.  JEM Advisory Editorial Board: Increasing diversity.. J Exp Med.
Nathan CF, Nussenzweig MC, Pulvirenti T.  2019.  JEM Editorial Board: Expanding on the basis of cancer.. J Exp Med. 216(8):1725.
Nathan C.  2013.  A journey in science: promise, purpose, privilege.. Mol Med. 19(1):305-13.
Kafsack BFC, Carruthers VB, Pineda FJ.  2007.  Kinetic modeling of Toxoplasma gondii invasion.. J Theor Biol. 249(4):817-25.
Nathan C.  2017.  Kunkel Lecture: Fundamental immunodeficiency and its correction.. J Exp Med. 214(8):2175-2191.
Eggink D, Melchers M, Wuhrer M, van Montfort T, Dey AK, Naaijkens BA, David KB, Le Douce V, Deelder AM, Kang K et al..  2010.  Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function.. Virology. 401(2):236-47.
Johnson EO, LaVerriere E, Office E, Stanley M, Meyer E, Kawate T, Gomez JE, Audette RE, Bandyopadhyay N, Betancourt N et al..  2019.  Large-scale chemical-genetics yields new M. tuberculosis inhibitor classes.. Nature. 571(7763):72-78.
Rubin BP, Li D, Holloman WK.  1994.  The LEU1 gene of Ustilago maydis.. Gene. 140(1):131-5.
Burton DR, Hessell AJ, Keele BF, Klasse PJohan, Ketas TA, Moldt B, D Dunlop C, Poignard P, Doyle LA, Cavacini L et al..  2011.  Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody.. Proc Natl Acad Sci U S A. 108(27):11181-6.
Lovejoy CA, Li W, Reisenweber S, Thongthip S, Bruno J, de Lange T, De S, Petrini JHJ, Sung PA, Jasin M et al..  2012.  Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.. PLoS Genet. 8(7):e1002772.
Sutherland JH, Holloman WK.  2018.  Loss of Cohesin Subunit Rec8 Switches Rad51 Mediator Dependence in Resistance to Formaldehyde Toxicity in .. Genetics. 210(2):559-572.
Cheng Y-W, Idrees K, Shattock R, Khan SA, Zeng Z, Brennan CW, Paty P, Barany F.  2010.  Loss of imprinting and marked gene elevation are 2 forms of aberrant IGF2 expression in colorectal cancer.. Int J Cancer. 127(3):568-77.
Gaur RL, Ren K, Blumenthal A, Bhamidi S, González-Nilo FD, Gibbs S, Jackson M, Zare RN, Ehrt S, Ernst JD et al..  2014.  LprG-mediated surface expression of lipoarabinomannan is essential for virulence of Mycobacterium tuberculosis.. PLoS Pathog. 10(9):e1004376.
Blumenthal A, Nagalingam G, Huch JH, Walker L, Guillemin GJ, Smythe GA, Ehrt S, Britton WJ, Saunders BM.  2012.  M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection.. PLoS One. 7(5):e37314.
Chookajorn T, Costanzo MS, Hartl DL, Deitsch KW.  2007.  Malaria: a peek at the var variorum.. Trends Parasitol. 23(12):563-5.
Deitsch KW, Calderwood MS, Wellems TE.  2001.  Malaria. Cooperative silencing elements in var genes.. Nature. 412(6850):875-6.
Kirkman L, Lawrence EA, Deitsch K.  2014.  Malaria parasites utilize both homologous recombination and alternative end joining pathways to maintain genome integrity.. Nucleic Acids Res. 42(1):370-9.
Deitsch KW.  2005.  Malaria virulence genes controlling expression through chromatin modification.. Cell. 121(1):1-2.
Deitsch KW.  2009.  A mark of silence in malaria parasites.. Cell Host Microbe. 5(2):112-3.
Forslund A, Zeng Z, Qin L-X, Rosenberg S, Ndubuisi MK, Pincas H, Gerald W, Notterman DA, Barany F, Paty PB.  2008.  MDM2 gene amplification is correlated to tumor progression but not to the presence of SNP309 or TP53 mutational status in primary colorectal cancers.. Mol Cancer Res. 6(2):205-11.
Shi C, Geders TW, Park SWoong, Wilson DJ, Boshoff HI, Abayomi O, Barry CE, Schnappinger D, Finzel BC, Aldrich CC.  2011.  Mechanism-based inactivation by aromatization of the transaminase BioA involved in biotin biosynthesis in Mycobaterium tuberculosis.. J Am Chem Soc. 133(45):18194-201.